TRPV1 and breast carcinoma: Subcellular localization of TRPV1 carries potential clinical meaning: “classical” (plasma membrane/cytoplasmic) distribution correlates with better prognosis, whereas “non-classical” ER/Golgi-centric aggregates associate with poorer survival in breast cancer specimens [12].